Further, if certain RNA editing events are preferentially presented via HLA molecules on tumor cells in preference to normal cells, these may represent valid targets (despite RNA editing in both normal and tumor cells) as shown for CCNI editing in some adult cancers [53], an editing event which we also observed in all pediatric cancer types analyzed (Supplementary Tables 3–4). The gene discussed is CCNI; the disease is cancer.